Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indigo Carmine for Delineation of Brain Tumor Borders
NCT01767415Phase 2Completed
- Sponsor
- Weill Cornell Medicine
- Start
- Apr 2012
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of indigotindisulfonate sodium in low-grade glioma (LGG), brain tumor, sponsored by Weill Cornell Medicine. Started Apr 2012; status: completed.
02
Drugs
indigotindisulfonate sodium
03
Conditions
low-grade glioma (LGG)brain tumor
Beyond the preview
Go deeper on NCT01767415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01767415.